This content was archived on July 7, 2014.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
Notice to the reader: The online consultation is now closed.
The health and safety of Canadian patients is a top priority for the Government of Canada, and as such, Health Canada is undertaking a public consultation with Canadians on drug shortage notification. The purpose is to seek feedback from Canadians and other key stakeholders on the current approach to drug shortage notification in Canada, on how this approach is meeting their needs for timely, comprehensive and reliable public information, and to chart the best path forward. Comments received from this consultation will be taken into account when assessing how well the current system is working.
You are not required to divulge any personal information in the provision of your answers. Any personal information you choose to provide is protected under the provisions of the Privacy Act. That Act also includes the right of access to and correction of your personal information. Should you require clarification about this Statement, contact our Access to Information and Privacy Coordinator.
This online consultation on drug shortage notification is open for comment starting May 22 to July 5, 2014 (45 calendar days). There are several ways to participate:
For more information on Health Canada's roles and responsibilities with respect to drug shortages, please visit the Health Canada Drug Shortages Webpage.
For more information on any drugs currently in shortage, please visit the Canadian Drug Shortage Website (www.drugshortages.ca).
If you have any questions, contact us at the email@example.com.